Friedlander, T. W., Beck, J. T., Rosenbaum, E., Peer, A., Hatakeyama, S., Jahchan, N., Zhou, C., Ferlini, C., Jha, S., Ngo, D. A., Galsky, M. D. (2025). A phase 2, open-label, randomized study of livmoniplimab in combination with budigalimab versus chemotherapy in patients with metastatic urothelial carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps4618